David Pass

Chief Operating Officer at GELESIS INC

Net worth: 319 $ as of 31/12/2023

56 year

Health Technology

Consumer Services

Profile

David Pass is currently a Director at Gelesis Srl and a Chief Operating & Commercial Officer at Gelesis, Inc. He previously worked as a Director-Marketing at Bristol-Myers Squibb Pharma Co., Vice President-Marketing at Johnson & Johnson, and Vice President-Marketing at Boehringer Ingelheim Corp.
He also briefly served as Chief Operating & Commercial Officer at Gelesis Holdings, Inc. Dr. Pass received his undergraduate and doctorate degrees from Philadelphia College of Pharmacy.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
GELESIS HOLDINGS, INC. 0.22%	17/03/2023	159,627 ( 0.22% )	319 $	31/12/2023

David Pass active positions

Companies	Position	Start
GELESIS INC	Chief Operating Officer	01/09/2016
Gelesis Srl Gelesis Srl BiotechnologyHealth Technology Gelesis Srl engages in the manufacture, research, and development of treatment solutions and interventions for gastrointestinal diseases. It also develops products and technologies which offers solutions to induce weight loss, improve glycemic control, and manage blood sugar levels in overweight and obese patients, including those with prediabetes and type 2 diabetes. The company was founded in 2009 and is headquartered in Calimera, Italy.	Director/Board Member	-

All active positions of David Pass

Former positions of David Pass

Companies	Position	End
GELESIS HOLDINGS, INC.	Chief Operating Officer	30/10/2023
Boehringer Ingelheim Corp. Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT.	Sales & Marketing	01/08/2016
JOHNSON & JOHNSON	Sales & Marketing	01/01/2008
Bristol-Myers Squibb Pharma Co.	Sales & Marketing	01/07/2002

See the detail of David Pass's experience

Training of David Pass

Philadelphia College of Pharmacy

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Pass's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
GELESIS HOLDINGS, INC.	Health Technology
JOHNSON & JOHNSON	Health Technology

Private companies	4
Gelesis, Inc. Gelesis, Inc. BiotechnologyHealth Technology Gelesis, Inc. operates as a consumer-centered biotherapeutics company, which engages in the development of novel therapies to induce weight loss and metabolic disorders. Its commercial product portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease /Non-alcoholic Steatohepatitis, and Functional Constipation. The company was founded by Yishai Zohar in 2006 and is headquartered in Boston, MA.	Health Technology
Gelesis Srl Gelesis Srl BiotechnologyHealth Technology Gelesis Srl engages in the manufacture, research, and development of treatment solutions and interventions for gastrointestinal diseases. It also develops products and technologies which offers solutions to induce weight loss, improve glycemic control, and manage blood sugar levels in overweight and obese patients, including those with prediabetes and type 2 diabetes. The company was founded in 2009 and is headquartered in Calimera, Italy.	Health Technology
Boehringer Ingelheim Corp. Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT.	Health Technology
Bristol-Myers Squibb Pharma Co.

See company connections